Preventive measures against coronavirus: Turkmenistan strengthens the stock of medicines and disinfectants

Preventive measures against coronavirus: Turkmenistan strengthens the stock of medicines and disinfectants

Turkmenistan is stepping up measures to prevent imported infection cases later on into the country by another preventive step in addition to timely taken measures to contain the outbreak amid the coronavirus global pandemic. The Ministry of Health and Medical Industry is strengthening the stock of medicines and disinfectants through both domestic production and import.

ORIENT contacted the representative of the Medical Ministry of Turkmenistan to find out what the “assortment” of such a resource includes, as many countries with COVID-19 outbreaks have a shortage of it.

According to the official, there is a sufficient reserve of personal and collective protective equipment. It includes kits for medical staff (a special suit, shoe covers, boots, glasses, disposable gloves, etc.), medical protective masks, non-contact thermometers, disinfectant to sanitize indoor places, oxolinic ointment, vitamin complexes, antiviral drugs, etc., as well as the a Triazavirin drug, large batch of which Turkmenistan purchased from Russia.

Earlier, TASS reported it citing to Aleksandr Petrov, Chairman of the Board of Directors at the drug producer Medsintez, which developed the medicine.

It was informed earlier, the company sent a batch of Triazavirin to China as humanitarian aid.

“We delivered [the drug] to Turkmenistan. This is not a humanitarian party, funds were allocated, and they purchased it for themselves. The batch was large, around 2 thousand packs. In one pack of 20 capsules,” Petrov told the agency.

He has noted that negotiations are underway on delivery of Russian drug Triazavirin to Armenia. “We are waiting for permission to import it to South Korea, but there are difficulties with the customs legislation on unregistered drugs. We are also in talks with Italy over possible clinical tests of Triazavirin there. But it would take a quite long time also as their legislation on clinical tests differs that China or Russia have,” Petrov said.

Triazavirin is a direct-acting Russian antiviral drug of the azoloazine family. According to the developers, effective against 15 types of flu. Developed by scientists of the Ural Federal University, Institute of Organic Synthesis. Postovsky Ural Branch of the Russian Academy of Sciences and the Research Institute of Influenza of the Ministry of Health of the Russian Federation.